Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Gene

NTRK1

3 articles · Resources: NCBI Gene, OncoKB

Clinical · Molecular biology

Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma

Toda S, Kasajima R, Okubo Y, et al.

Anticancer research

This study evaluated the utility of RNA sequencing and immunohistochemistry (IHC) for detecting NTRK fusions in thyroid carcinoma, particularly those potentially missed by gene panel testing. Two patient groups were analyzed: advanced thyroid cancer cases undergoing panel testing and surgical papillary thyroid carcinoma cases screened by IHC. Results indicated that a gene panel test missed one SQSTM1-NTRK3 fusion, while pan-TRK IHC showed variable sensitivity depending on the fusion type. The study concludes that active screening for NTRK fusions is desirable, especially in patients without MAPK pathway abnormalities or with positive pan-TRK staining.

Clinical · Molecular biology

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis

Gao R, Li Z, Huang J, et al.

Lung cancer (Amsterdam, Netherlands)

This multicenter retrospective study analyzed 163 patients with transformed small-cell lung cancer (T-SCLC), a recognized resistance mechanism in EGFR-mutant lung adenocarcinoma. The study aimed to identify early predictors of histological transformation and evaluate post-transformation treatment outcomes. Researchers found a median transformation time of 25.8 months and a median post-transformation overall survival of 14.2 months in EGFR-mutant patients. A predictive model was developed, incorporating age, RB1/NTRK1 mutations, and secondary EGFR T790M mutation as independent risk factors. Taxane-based regimens emerged as a promising later-line therapeutic option for T-SCLC.

Molecular biology

Detecting Rare ALK Gene Fusions in Unclassified Spindle Cell Lung Tumors Using Anchored Multiplex PCR/Targeted RNA Next-Generation Sequencing

Masago K, Seto K, Sasaki E, et al.

Genes, chromosomes & cancer

This study investigated oncogenic fusions in 11 unclassified pulmonary spindle cell tumors, aggressive neoplasms with limited treatment options. Using anchored multiplex PCR-based targeted RNA sequencing, researchers identified ALK gene fusions in two patients (18.2%), specifically PPFIBP1::ALK and SYCL3::ALK. Both tumors also exhibited positive ALK immunohistochemical staining, despite showing morphological heterogeneity. These findings expand the molecular spectrum of these rare tumors and highlight the importance of detecting ALK fusions, including those with uncommon partners.